Compile Data Set for Download or QSAR
maximum 50k data
Found 995 with Last Name = 'sampognaro' and Initial = 'a'
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM82070(CAS_29790-52-1 | NICOTINE-L (BASE) | Nicotine-D sa...)
Affinity DataKi:  2.30nMAssay Description:Binding affinity in rat forebrain against Nicotinic acetylcholine receptor alpha4-beta2More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093255((+)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidi...)
Affinity DataKi:  92nMAssay Description:binding affinity in rat hippocampi against alpha7 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093255((+)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidi...)
Affinity DataKi:  92nMAssay Description:binding affinity in rat hippocampi against alpha7 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093259(3'-Ethylspiro[1-azabicyclo[2.2.2]octane-3,5'-oxazo...)
Affinity DataKi:  170nMAssay Description:Binding affinity in rat forebrain against Nicotinic acetylcholine receptor alpha4-beta2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi:  250nMAssay Description:binding affinity in rat hippocampi against alpha7 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi:  250nMAssay Description:binding affinity in rat hippocampi against alpha7 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi:  450nMAssay Description:binding affinity in rat forebrain against alpha4-beta2 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi:  450nMAssay Description:binding affinity in rat forebrain against alpha4-beta2 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM82070(CAS_29790-52-1 | NICOTINE-L (BASE) | Nicotine-D sa...)
Affinity DataKi:  480nMAssay Description:Binding affinity in rat hippocampi against Nicotinic acetylcholine receptor alpha7More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093251(CHEMBL338698 | Spiro[1-azabicyclo[2.2.2]octane-3,5...)
Affinity DataKi:  560nMAssay Description:Binding affinity in rat hippocampi against Nicotinic acetylcholine receptor alpha7More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093259(3'-Ethylspiro[1-azabicyclo[2.2.2]octane-3,5'-oxazo...)
Affinity DataKi:  690nMAssay Description:Binding affinity in rat hippocampi against Nicotinic acetylcholine receptor alpha7More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093251(CHEMBL338698 | Spiro[1-azabicyclo[2.2.2]octane-3,5...)
Affinity DataKi:  2.20E+3nMAssay Description:Binding affinity in rat forebrain against Nicotinic acetylcholine receptor alpha4-beta2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093260(CHEMBL133295 | Spiro[1-azabicyclo[2.2.2]octane-3,5...)
Affinity DataKi:  3.70E+3nMAssay Description:Binding affinity in rat hippocampi against Nicotinic acetylcholine receptor alpha7More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093257(CHEMBL131574 | Spiro[1-azabicyclo[2.2.2]octane-3,4...)
Affinity DataKi:  4.00E+3nMAssay Description:Binding affinity in rat hippocampi against Nicotinic acetylcholine receptor alpha7More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093256(CHEMBL130205 | Spiro[1-azabicyclo[2.2.2]octane-3,4...)
Affinity DataKi: >4.30E+3nMAssay Description:Binding affinity in rat hippocampi against Nicotinic acetylcholine receptor alpha7More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093255((+)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidi...)
Affinity DataKi:  9.40E+3nMAssay Description:binding affinity in rat hippocampi against alpha7 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093252(CHEMBL422259 | Spiro[1-azabicyclo[2.2.2]octane-3,4...)
Affinity DataKi:  1.10E+4nMAssay Description:Binding affinity in rat forebrain against Nicotinic acetylcholine receptor alpha4-beta2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093258(3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,4'-2H-t...)
Affinity DataKi: >1.30E+4nMAssay Description:Binding affinity in rat hippocampi against Nicotinic acetylcholine receptor alpha7More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093252(CHEMBL422259 | Spiro[1-azabicyclo[2.2.2]octane-3,4...)
Affinity DataKi: >1.30E+4nMAssay Description:Binding affinity in rat hippocampi against Nicotinic acetylcholine receptor alpha7More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093255((+)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidi...)
Affinity DataKi:  1.60E+4nMAssay Description:binding affinity in rat forebrain against alpha4-beta2 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093255((+)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidi...)
Affinity DataKi:  1.60E+4nMAssay Description:binding affinity in rat forebrain against alpha4-beta2 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093254(CHEMBL336197 | Spiro[1-azabicyclo[2.2.2]octane-3,6...)
Affinity DataKi:  2.30E+4nMAssay Description:Binding affinity in rat hippocampi against Nicotinic acetylcholine receptor alpha7; value range is 1000.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi:  2.40E+4nMAssay Description:binding affinity in rat forebrain against alpha4-beta2 nicotinic receptor; value range is 1000.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-7(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093253((+)-3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-...)
Affinity DataKi: >3.20E+4nMAssay Description:binding affinity in rat hippocampi against alpha7 nicotinic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuronal acetylcholine receptor subunit alpha-4/beta-2(Rattus norvegicus (Rat))
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50093258(3'-Methylspiro[1-azabicyclo[2.2.2]octane-3,4'-2H-t...)
Affinity DataKi:  3.50E+4nMAssay Description:Binding affinity in rat forebrain against Nicotinic acetylcholine receptor alpha4-beta2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274527(N-(6-(4-(4-fluorophenyl)-1- (1-(2-hydroxyethyl)pip...)
Affinity DataIC50:  0.0340nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274578(2-fluoro-N-(6-(4-(4- fluorophenyl)-1-(1- (2-hydrox...)
Affinity DataIC50:  0.0340nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274525(N-(6-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imi...)
Affinity DataIC50:  0.0600nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274432(N-(6-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imi...)
Affinity DataIC50:  0.0640nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274471(N-(6-(1-(1-(2-aminoacetyl)piperidin-4- yl)-4-(4-fl...)
Affinity DataIC50:  0.0850nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274530(N-(6-(1-(1-(2-amino-2- oxoethyl)piperidin-4-yl)-4-...)
Affinity DataIC50:  0.0910nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform epsilon(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274527(N-(6-(4-(4-fluorophenyl)-1- (1-(2-hydroxyethyl)pip...)
Affinity DataIC50:  0.0950nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274618(N-(6-(2-(4-fluorophenyl) imidazo[1,2-a]pyridin-3-y...)
Affinity DataIC50:  0.0960nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform epsilon(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274535(N-(6-(4-(4-fluorophenyl)- 1-(1-(2-hydroxyethyl) pi...)
Affinity DataIC50:  0.0960nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274886(2-Fluoro-N-(6-(2-(4-fluorophenyl)-7-pivaloyl- 5,6,...)
Affinity DataIC50:  0.100nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274453(N-(6-(1-(1-((1,3-dimethyl-1H-pyrazol-4- yl)methyl)...)
Affinity DataIC50:  0.101nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274594(N-(6-(4-(4-fluorophenyl)-1- (2-morpholinoethyl)-1H...)
Affinity DataIC50:  0.104nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274718(N-(6-(4-(4-chlorophenyl)-1-(2- fluoroethyl)-2-meth...)
Affinity DataIC50:  0.109nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274713(2-Fluoro-N-(6-(1-(2-fluoroethyl)-4-(4-fluorophenyl...)
Affinity DataIC50:  0.110nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274595(N-(6-(4-(4-fluorophenyl)-1- (2-morpholinoethyl)-1H...)
Affinity DataIC50:  0.110nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274619(2-(dimethylamino)-N-(6-(2-(4- fluorophenyl)imidazo...)
Affinity DataIC50:  0.111nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274571((S)-2-fluoro-N-(6-(4-(4- fluorophenyl)-2-methyl-1-...)
Affinity DataIC50:  0.112nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274498(N-(6-(1-(1-(3,3- difluorocyclobutanecarbonyl)piper...)
Affinity DataIC50:  0.116nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274720(N-(6-(4-(4-chlorophenyl)-2-methyl- 1-(2,2,2-triflu...)
Affinity DataIC50:  0.126nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274472(2-fluoro-N-(6-(4-(4-fluorophenyl)-1-(1- (2-hydroxy...)
Affinity DataIC50:  0.128nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform epsilon(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274530(N-(6-(1-(1-(2-amino-2- oxoethyl)piperidin-4-yl)-4-...)
Affinity DataIC50:  0.128nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274487(2-fluoro-N-(6-(4-(4-fluorophenyl)-1-(1 isonicotino...)
Affinity DataIC50:  0.130nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274465(2-fluoro-N-(6-(4-(4-fluorophenyl)-1-(1- (2-methoxy...)
Affinity DataIC50:  0.136nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274513(3,3,3-trifluoropropyl 4-(5-(2-(2- fluoroisonicotin...)
Affinity DataIC50:  0.142nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM274500(N-(6-(1-(1-(3- chloropropanoyl)piperidin-4-yl)-4-(...)
Affinity DataIC50:  0.143nMpH: 7.4 T: 2°CAssay Description:The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 995 total ) | Next | Last >>
Jump to: